Pharmafile Logo

VJOncology

- PMLiVE

Bedrock Group bolsters team with three key appointments

Andy Jobson, Deborah Blain and Vicky O'Connor join company

- PMLiVE

Menlo slumps as itching drug fails mid-stage trial

Shares in US biotech closed down almost a third after announcement

- PMLiVE

Trial of Amgen, Servier’s heart failure drug clears interim check

Drug could become a $2bn product if approved

Miranda Dini

AVENIR GLOBAL appoints global healthcare lead

Mirandi Dini expands role at communications firm

- PMLiVE

Policy and public health: all the decisions we can’t see

January was a bad month for healthcare in China

- PMLiVE

AXON recognised for ‘excellence in wellbeing’ by Great Place to Work

Healthcare comms company wins recognition for second year in a row

The ALS patient journey

Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...

Blue Latitude Health

- PMLiVE

Genentech pays $30m upfront to access Bicycle Therapeutic’s discovery technology

Collaboration will focus on discovery of immuno-oncology therapies

- PMLiVE

Takeda buys coeliac disease partner PvP Biologics after phase 1 win

Deal includes upfront payment plus up to $330m in milestones

- PMLiVE

IMV preps pivotal trials for ovarian cancer T cell therapy

Drug stabilised disease in 79% of 19 evaluable patients

- PMLiVE

Mallinckrodt reaches tentative $1.6bn opioid settlement

Agreement reached with a plaintiff's executive committee

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links